Here’s what you should know:
1. Henry Schein’s sales increased 6.5 percent year-over-year.
2. Henry Schein’s net adjusted income for the second quarter was $136.1 million or $1.71 per diluted share.
3. Concerning its medical sector, Henry Schein reported $571.4 million in sales, which was a 6.1 percent increase year-over-year.
4. Henry Schein CEO Stanley Bergman said in a release, “We believe continued market share gains in our medical group are the result of our ability to meet the needs of a dynamic, evolving healthcare market, particularly among large group practices, where we expect to see further consolidation.”
5. Concerning rest-of-year outlooks, Henry Schein expects adjusted diluted earnings per share between $7.13 and $7.26, which includes a $0.04 litigation settlement response.
6. During the second quarter, Henry Schein repurchased 289,000 shares of its common stock at an average price of $173.16 per share. It had no impact on second quarter diluted earnings.
More articles on improving performance:
WellSpan Health to build outpatient surgery suite — 4 highlights
Essentia Health makes progress on Lakewood Surgery Center partnership; breaks ground on clinic
23 statistics on average salary for top 5 most-recruited specialties by practice setting
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
